---
pmid: '26878725'
title: Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant
  nephrotic syndrome.
authors:
- Braun DA
- Sadowski CE
- Kohl S
- Lovric S
- Astrinidis SA
- Pabst WL
- Gee HY
- Ashraf S
- Lawson JA
- Shril S
- Airik M
- Tan W
- Schapiro D
- Rao J
- Choi WI
- Hermle T
- Kemper MJ
- Pohl M
- Ozaltin F
- Konrad M
- Bogdanovic R
- Büscher R
- Helmchen U
- Serdaroglu E
- Lifton RP
- Antonin W
- Hildebrandt F
journal: Nat Genet
year: '2016'
full_text_available: false
pmcid: PMC4811732
doi: 10.1038/ng.3512
---

# Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome.
**Authors:** Braun DA, Sadowski CE, Kohl S, Lovric S, Astrinidis SA, Pabst WL, Gee HY, Ashraf S, Lawson JA, Shril S, Airik M, Tan W, Schapiro D, Rao J, Choi WI, Hermle T, Kemper MJ, Pohl M, Ozaltin F, Konrad M, Bogdanovic R, Büscher R, Helmchen U, Serdaroglu E, Lifton RP, Antonin W, Hildebrandt F
**Journal:** Nat Genet (2016)
**DOI:** [10.1038/ng.3512](https://doi.org/10.1038/ng.3512)
**PMC:** [PMC4811732](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811732/)

## Abstract

1. Nat Genet. 2016 Apr;48(4):457-65. doi: 10.1038/ng.3512. Epub 2016 Feb 15.

Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant 
nephrotic syndrome.

Braun DA(1), Sadowski CE(1), Kohl S(1), Lovric S(1), Astrinidis SA(2), Pabst 
WL(1), Gee HY(1)(3), Ashraf S(1), Lawson JA(1), Shril S(1), Airik M(1), Tan 
W(1), Schapiro D(1), Rao J(1), Choi WI(1), Hermle T(1), Kemper MJ(4), Pohl M(5), 
Ozaltin F(6)(7)(8), Konrad M(9), Bogdanovic R(10), Büscher R(11), Helmchen 
U(12), Serdaroglu E(13), Lifton RP(14)(15), Antonin W(2), Hildebrandt F(1)(15).

Author information:
(1)Department of Medicine, Boston Children's Hospital, Harvard Medical School, 
Boston, Massachusetts, USA.
(2)Friedrich Miescher Laboratory, Max Planck Society, Tübingen, Germany.
(3)Department of Pharmacology, Brain Korea 21 PLUS Project for Medical Sciences, 
Yonsei University College of Medicine, Seoul, Korea.
(4)Department of Pediatrics, University Medical Center Hamburg-Eppendorf, 
Hamburg, Germany.
(5)Department of Pediatrics and Adolescent Medicine, University of Freiburg 
Medical Center, Freiburg, Germany.
(6)Department of Pediatric Nephrology, Hacettepe University Faculty of Medicine, 
Ankara, Turkey.
(7)Nephrogenetics Laboratory, Hacettepe University, Ankara, Turkey.
(8)Center for Biobanking and Genomics, Hacettepe University, Ankara, Turkey.
(9)Department of General Pediatrics, University Hospital Münster, Münster, 
Germany.
(10)Medical Faculty, University of Belgrade, Belgrade, Serbia.
(11)Department of Pediatrics II, Pediatric Nephrology, University of 
Duisburg-Essen, Essen, Germany.
(12)Institute of Pathology, Kidney Registry, University Hospital 
Hamburg-Eppendorf, Hamburg, Germany.
(13)Department of Pediatric Nephrology, Dr. Behçet Uz Children Hospital, Izmir, 
Turkey.
(14)Department of Genetics, Yale University School of Medicine, New Haven, 
Connecticut, USA.
(15)Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.

Comment in
    Nat Rev Nephrol. 2016 Apr;12(4):195. doi: 10.1038/nrneph.2016.29.

Nucleoporins are essential components of the nuclear pore complex (NPC). Only a 
few diseases have been attributed to NPC dysfunction. Steroid-resistant 
nephrotic syndrome (SRNS), a frequent cause of chronic kidney disease, is caused 
by dysfunction of glomerular podocytes. Here we identify in eight families with 
SRNS mutations in NUP93, its interaction partner NUP205 or XPO5 (encoding 
exportin 5) as hitherto unrecognized monogenic causes of SRNS. NUP93 mutations 
caused disrupted NPC assembly. NUP93 knockdown reduced the presence of NUP205 in 
the NPC, and, reciprocally, a NUP205 alteration abrogated NUP93 interaction. We 
demonstrate that NUP93 and exportin 5 interact with the signaling protein SMAD4 
and that NUP93 mutations abrogated interaction with SMAD4. Notably, NUP93 
mutations interfered with BMP7-induced SMAD transcriptional reporter activity. 
We hereby demonstrate that mutations of NUP genes cause a distinct renal disease 
and identify aberrant SMAD signaling as a new disease mechanism of SRNS, opening 
a potential new avenue for treatment.

DOI: 10.1038/ng.3512
PMCID: PMC4811732
PMID: 26878725 [Indexed for MEDLINE]
